Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin and MDMA for the treatment of trauma-related psychopathology
Catherine Bird, Nadav Liam Modlin, James Rucker
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 229-249
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 94
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model
Bill Brennan, Alexander B. Belser
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 48
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 33
A Comprehensive Overview of the Role of Visual Cortex Malfunction in Depressive Disorders: Opportunities and Challenges
Fangfang Wu, Qing-Bo Lu, Yan Kong, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 9, pp. 1426-1438
Open Access | Times Cited: 31
Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity
Yingjie Du, Yunfeng Li, Xiangting Zhao, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 31
Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial
Shakila Meshkat, Richard J. Zeifman, Kathleen E. Stewart, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313741-e0313741
Open Access | Times Cited: 1
Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications
Taynah Pereira Galdino, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 380-380
Open Access
Wild and Cultivated Mushrooms Exhibit Anti-Inflammatory Effects Including Inhibition of Platelet Aggregation and Interleukin-8 Expression
Hiroaki Yoshimoto, Noriko Miyazawa, Fumio Eguchi
Applied Microbiology (2025) Vol. 5, Iss. 2, pp. 36-36
Open Access
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD
Alan K. Davis, Adam W. Levin, Paul Nagib, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e068884-e068884
Open Access | Times Cited: 11
Psychedelic discourses: A qualitative study of discussions in a Danish online forum
Søren Holm, Margit Anne Petersen, Oskar Enghoff, et al.
International Journal of Drug Policy (2023) Vol. 112, pp. 103945-103945
Open Access | Times Cited: 10
Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis
Christoffer Dharma, Esther Liu, Daniel Grace, et al.
Journal of Epidemiology & Community Health (2024) Vol. 78, Iss. 4, pp. 248-254
Closed Access | Times Cited: 3
DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites
Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, et al.
Applied and Environmental Microbiology (2022) Vol. 88, Iss. 24
Open Access | Times Cited: 15
Psilocybin-Assisted Psychotherapy as a Potential Treatment for Eating Disorders: a Narrative Review of Preliminary Evidence
Elena Koning, Elisa Brietzke
Trends in Psychiatry and Psychotherapy (2023)
Open Access | Times Cited: 7
Development of the Japanese version of the Ego‐Dissolution Inventory (EDI)
Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 1, pp. 292-297
Open Access | Times Cited: 2
A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
Michael A. Norred, Zachary D. Zuschlag, Mark B. Hamner
Drugs (2024) Vol. 84, Iss. 2, pp. 149-164
Closed Access | Times Cited: 2
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Applications of functional neurotransmitter release imaging with genetically encoded sensors in psychiatric research
Emily C. Wright, Erin M. Scott, Lin Tian
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 269-273
Open Access | Times Cited: 2
Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon
Kawther N Elsouri, Sahand Kalhori, Diego Colunge, et al.
Cureus (2022)
Open Access | Times Cited: 11
Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder
Xénia Gonda, Péter Döme, B. Erdelyi-Hamza, et al.
European Neuropsychopharmacology (2022) Vol. 61, pp. 17-29
Closed Access | Times Cited: 11
Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
Lakshan N Fonseka, Benjamin K.P. Woo
World Journal of Psychiatry (2023) Vol. 13, Iss. 5, pp. 182-190
Open Access | Times Cited: 6
Psychedelika in der Psychiatrie – Entwicklungen und die Stellung in Deutschland
Uwe Herwig, Lea J. Mertens, Sergio Pérez Rosal, et al.
Fortschritte der Neurologie · Psychiatrie (2023) Vol. 91, Iss. 07/08, pp. 311-318
Closed Access | Times Cited: 5
Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
Nadav Liam Modlin, Michael Creed, Maria Sarang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 109-135
Open Access | Times Cited: 1
Development of the Enthusiastic Substance Use Attitudes Scale: Preliminary Evidence of a Novel Maintenance Factor
Bryant M. Stone
Substance Use & Misuse (2024) Vol. 59, Iss. 4, pp. 494-509
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top